Hormone Replacement Therapy, Likely Neither Angel Nor Demon.

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med (2003) 13.81

The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med (2007) 12.23

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA (2003) 10.61

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet (1997) 10.28

Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med (2011) 8.19

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. J Natl Cancer Inst (2005) 5.55

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA (2011) 3.85

Male breast cancer. Lancet (2006) 3.41

Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials. JAMA Oncol (2015) 3.13

Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol (2013) 2.21

DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Int J Cancer (2003) 2.18

Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women. Cancer Epidemiol Biomarkers Prev (2010) 1.66

Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010. Breast Cancer Res Treat (2012) 1.66

Nottingham grades of lobular carcinoma lack the prognostic implications they bear for ductal carcinoma. J Surg Res (2010) 1.44

Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol (2000) 1.34

A decline in breast-cancer incidence. N Engl J Med (2007) 1.00

The use of tamoxifen and raloxifene for the prevention of breast cancer. Recent Results Cancer Res (2009) 0.89

Oestrogen and breast cancer: results from the WHI trial. Lancet Oncol (2012) 0.83

A decline in breast-cancer incidence. N Engl J Med (2007) 0.82

A decline in breast-cancer incidence. N Engl J Med (2007) 0.78